Search Prime Grants

W58P052220009

Cooperative Agreement

Overview

Grant Description
Covid-19 action. Industrial base expansion cooperative agreement to Exela Pharma Sciences, LLC (EXELA).
Awardee
Exela Pharma Sciences
Grant Program (CFDA)
12.360 - Research on Chemical and Biological Defense
Awarding Agency
ACC Aberdeen Proving Ground (APG) [DoD - USA - AMC - ACC]
Funding Agency
Joint PEO for Chemical, Biological, Radiological and Nuclear Defense (JPEOCRBND) [DoD - USA - USAASC]
Place of Performance
Lenoir, North Carolina 286453618 United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Exela Pharma Sciences was awarded Covid-19 Action: Industrial Base Expansion for Exela Pharma Cooperative Agreement W58P052220009 worth $40,402,738 from Joint PEO for Chemical, Biological, Radiological and Nuclear Defense in May 2022 with work to be completed primarily in Lenoir North Carolina United States. The grant has a duration of 12 years and was awarded through assistance program 12.360 Research on Chemical and Biological Defense.

Status
(Ongoing)

Last Modified 11/14/22

Period of Performance
5/5/22
Start Date
5/4/34
End Date
29.0% Complete

Funding Split
$40.4M
Federal Obligation
$0.0
Non-Federal Obligation
$40.4M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to W58P052220009

Additional Detail

Award ID FAIN
W58P052220009
SAI Number
None
Award ID URI
None
Awardee Classifications
For-Profit Organization (Other Than Small Business)
Small Business
Other
Awarding Office
W58P05 W6QK ACC-APG NATICK
Funding Office
W56XNH W6DZ JPMO CBD JPMO MCS (06)
Awardee UEI
M6CZR21V9HX9
Awardee CAGE
7A4M2
Performance District
05
Senators
Thom Tillis
Ted Budd
Representative
Virginia Foxx
Modified: 11/14/22